Samsung Bioepis: Building a US Biosimilar Market That Lasts
Samsung Bioepis is expanding in the US biosimilars market, with ten FDA approvals so far, seven assets in development, and an ambitious target of 20 products on the market by…
Samsung Bioepis is expanding in the US biosimilars market, with ten FDA approvals so far, seven assets in development, and an ambitious target of 20 products on the market by…
Held September 22–23 in San Francisco, CA; the Summit will convene healthcare investors, industry leaders, and innovators to discuss the latest investment strategies and advances shaping the healthcare landscape Lawrenceville,…
International Healthcare Week Opens in Hong Kong from May Showcasing Investment Opportunities and Innovative Technologies Organized by the Hong Kong Trade Development Council (HKTDC), the 5th International Healthcare Week…
Menarini Asia-Pacific is pleased to announce the appointment of its new Chief Executive Officer, Mr. Glen Godresse, effective from March 1st, 2024. Glen brings over 25 years of pharmaceutical industry experience…
The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing of viruses and other pathogens…
Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sciences entrepreneurs. With the creation of the…
A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round. Headquartered at the EPFL Innovation Park…
Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19. The goal is to conduct clinical trials by fall 2021.…
Swedish biopharmaceutical group Ferring Pharmaceuticals has opened a state-of-the-art innovation center at Biopôle, adding a new hub for biologics research and development to the vibrant life sciences campus located…
Vaud-based MedAlliance has raised over USD 50 Million in equity funding for its novel balloon that provides a controlled sustained release of a limus drug. This financing will be…
The EPFL Innovation Park and Groupe Mutuel are joining forces to launch Tech4Eva, the first start-up acceleration program in Switzerland addressing women’s health. Studies indicate that…
Scientists at the University of Bern and Inselspital have established organoid culture models from prostate tumor biopsies. These are small clusters of cells which can be used to test the…
See our Cookie Privacy Policy Here
